Urine saturation and promoter/inhibitor parameters and ratios in renal stone disease caused by ceftriaxone

Urine saturation and promoter/inhibitor parameters and ratios in renal stone disease caused by ceftriaxone

Bibliographic Details
Main Authors:	Milošević Danko, Miše Branko, Habuš Ivan, Topalović-Grković Marija, Batinić Danica, Golubić Anja, Turudić Daniel
Format:	Article
Language:	English
Published:	De Gruyter 2013-06-01
Series:	Open Medicine
Subjects:	ceftriaxone urolythiasis urine saturation stone promoters/inhibitors
Online Access:	https://doi.org/10.2478/s11536-012-0091-z

Similar Items

Kidney Stones and Ceftriaxone
by: Murat Dursun, et al.
Published: (2015-01-01)

Ceftriaxone‐associated pseudolithiasis
by: Masaru Kurihara, et al.
Published: (2021-09-01)

Ceftriaxone treatment of syphilis
by: Georgiy L. Katunin, et al.
Published: (2021-04-01)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
by: Brigitte Lefebvre, et al.
Published: (2018-02-01)

Ceftriaxone-induced Agranulocytosis
by: Lénio Couto, et al.
Published: (2021-01-01)

Ceftriaxone Induced Unilateral Facial Angioedema
by: Recep Alanli
Published: (2019-05-01)

Ceftriaxone-associated nephrolithiasis and gallstone in adults
by: Azarkar G, et al.
Published: (2018-12-01)

The contribution of nano‐based strategies in overcoming ceftriaxone resistance: a literature review
by: Ashagrachew Tewabe, et al.
Published: (2021-08-01)

Asymptomatic ceftriaxone‐associated pseudolithiasis
by: Osamu Sasaki, et al.
Published: (2019-09-01)

Appropriate Use of Ceftriaxone in Sub-Saharan Africa: A Systematic Review
by: Meresa Bishaw B, et al.
Published: (2021-08-01)

Spectrophotometric Determination of Ceftriaxone Using 4-Dimethylaminobenzaldehyde
by: F.M.A. Rind*1, , , , , , and, et al.
Published: (2008-06-01)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
by: Alan R. Katz
Published: (2018-03-01)

Ceftriaxone-associated pseudolithiasis in hemodialysis patients: a case series study
by: Yuko Oyama, et al.
Published: (2021-02-01)

The Dark Purple Side of Ceftriaxone: A Case Report on Leucocytoclastic Vasculitis
by: Elia Rigamonti, et al.
Published: (2020-03-01)

PHARMACOKINETICS OF CEFTRIAXONE FOLLOWING INTRAMUSCULAR ADMINISTRATION IN LOCAL PIG OF MIZORUM, INDIA
by: Lalrin Puia, et al.
Published: (2016-12-01)

Water transport through rat colonic epithelium during ceftriaxone therapy
by: T. Dovbynchuk, et al.
Published: (2016-07-01)

Clinical Pharmacology of Ceftriaxone in Neonates and Infants: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-09-01)

Renal stone culture and sensitivity is a better predictor of potential urosepsis than pelvic or midstream urine culture and sensitivity
by: Rahul Devraj, et al.
Published: (2016-01-01)

Toxic epidermal necrolysis secondary to ceftriaxone use: A case report
by: Mustafa İçer, et al.
Published: (2015-12-01)

Morphological effect of Ceftriaxone on Pseudomonas aeruginosa and Proteus mirabilis
by: Mahmoud Zakei Alhaso
Published: (2009-06-01)

Preparation of modified magnetic nanoparticles for in vitro delivery of ceftriaxone
by: Arash Alipour, et al.
Published: (2019-04-01)

Gallblader sonographic abnormality following ceftriaxone treatment in children
by: Bazmamoun H (MD), et al.
Published: (2012-03-01)

Impact of Obesity on Ceftriaxone Efficacy
by: Katie E. Barber, et al.
Published: (2020-07-01)

Comparison of prevalence of hypercalciuria after intravenous injection of ceftriaxone versus ampicillin and cefotaxime in children with febrile infection
by: Maryam Esteghamati, et al.
Published: (2019-03-01)

Ceftriaxone-associated pancreatitis captured on serial computed tomography scans
by: Nozomu Nakagawa, MD, et al.
Published: (2018-02-01)

Response of HIV-infected patients with syphilis to therapy with penicillin or intravenous ceftriaxone
by: Spornraft-Ragaller P, et al.
Published: (2011-02-01)

The Effects of Ceftriaxone on Histology, Histomorphometry, and Histochemistry of Testis and Sperm Characteristics in Mice
by: Shapour Hasanzadeh, et al.
Published: (2016-08-01)

Ceftriaxone treatment for two neurosyphilis cases presenting with cognitive and psychiatric symptoms
by: Melek Kandemir, et al.
Published: (2011-06-01)

Ceftriaxone treatment for two neurosyphilis cases presenting with cognitive and psychiatric symptoms
by: Melek Kandemir, et al.
Published: (2011-06-01)

Fecal short-chain fatty acids at different time points after ceftriaxone administration in rats
by: Yu. V. Holota, et al.
Published: (2017-02-01)

Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda
by: Paul Kutyabami, et al.
Published: (2021-06-01)

Rare but not forgotten: A case of meningitis due to ceftriaxone-resistant Streptococcus pneumoniae
by: Naomi Hauser, et al.
Published: (2018-01-01)

Ceftriaxone concentration at the surgical site following systemic and isolated upper limb injection
by: Pankaj Kundra, et al.
Published: (2018-01-01)

A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction
by: Shuichi Abe
Published: (2017-01-01)

Cefazolin and ceftriaxone attenuate the cue-primed reinstatement of alcohol-seeking
by: Ana eWeiland, et al.
Published: (2015-03-01)

Ceftriaxone Therapy of Bacterial Meningitis in Children
by: Sumarmo Sumarmo, et al.
Published: (2019-07-01)

Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia
by: J.S. Mendonça, et al.

The Difference in The Effect Between The Oxygenated and Mineral Water on The O2 Saturation And Urine pH
by: Naila Shulya Ellyana, et al.
Published: (2011-12-01)

Urinary sludge caused by ceftriaxone in a young boy
by: Takahisa Kimata, et al.
Published: (2012-03-01)

Ceftriaxone induced drug rash with eosinophilia and systemic symptoms
by: Vivek S Guleria, et al.
Published: (2014-01-01)